Clin2
NCT07001787Possibly a fitNot yet recruiting

Safety of a new cholesterol-lowering pill in healthy adults

Dyslipidemia

Part of Hormones & metabolism clinical trials.

This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
88 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Aged 18 to 55 years
  • Generally healthy, with no major medical conditions
  • For some parts of the study, your LDL (bad) cholesterol must be in a certain range, and you may need to take a cholesterol medicine for a month first
  • Willing to avoid alcohol, smoking, caffeine, grapefruit, and certain foods during the study
  • Willing to use effective birth control and avoid donating sperm or eggs for a period after the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07777003Not yet recruiting· Phase 1
Study of HS-10582 for mildly elevated LDL cholesterol

This study tests a new medicine called HS-10582 to see if it is safe and how well it works in people with mildly high LDL cholesterol (the 'bad' cholesterol). It may help lower cholesterol levels and could be a future treatment option.

NCT06669429Recruiting· Phase 1
Safety study of RS-C1001 in healthy Chinese adults

This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.

Beijing
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu
NCT07724431Not yet recruiting· Phase 1
Testing a new cholesterol-lowering drug in healthy adults

This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.

Melbourne, Victoria
NCT06867406Not yet recruiting· Phase 1
Safety study of a new tablet in healthy adults

This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.

Beijing, Beijing Municipality
NCT07229937Recruiting· Phase 2
Testing an experimental drug for high cholesterol

This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.

Harbin, Heilongjiang

Hear when a new Dyslipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.